Cite

HARVARD Citation

    Tsukamoto, S. et al. (n.d.). Safety and efficacy of romiplostim in patients with eltrombopag‐resistant or ‐intolerant immune thrombocytopenia. British journal of haematology. pp. 286-289. [Online]. 
  
Back to record